| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3906075 | Urology | 2007 | 5 Pages |
Abstract
Adjuvant RT was not frequently used in men enrolled in CaPSURE. PSA recurrence was observed more frequently in men with high-risk disease, suggesting that adjuvant RT is not adequate therapy and that these men might benefit from the combined use of hormonal therapy and RT.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
O. Kenneth Macdonald, Anthony V. D'Amico, Natalia Sadetsky, Dennis C. Shrieve, Peter R. Carroll,